BONITA SPRINGS, Florida — A new digital therapeutic significantly improves abstinence and treatment retention in patients with opioid use disorder, results from a randomized controlled trial show.
BONITA SPRINGS, Florida — A new digital therapeutic significantly improves abstinence and treatment retention in patients with opioid use disorder, results from a randomized controlled trial show.
The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.
400 Massasoit Avenue
Suite 108
East Providence, RI 02914
(401) 524-3076
Contact Us